1	5 Patients on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide are eligible if the dose of the immunosuppressive drug has been stable for at least 3 months prior to enrollment and their hematologic parameters do not meet the exclusion criteria 1 as outlined below|immunosuppressive[136,153]|||||||3 months[188,196]|||5748|5748|immunosuppressive
1	5 Patients on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide are eligible if the dose of the immunosuppressive drug has been stable for at least 3 months prior to enrollment and their hematologic parameters do not meet the exclusion criteria 1 as outlined below|cyclophosphamide[87,103]|||||||||C0010583|3002|3002|cyclophosphamide
1	5 Patients on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide are eligible if the dose of the immunosuppressive drug has been stable for at least 3 months prior to enrollment and their hematologic parameters do not meet the exclusion criteria 1 as outlined below|azathioprine[74,86]|||||||||C0004482|1256|1256|azathioprine
1	5 Patients on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide are eligible if the dose of the immunosuppressive drug has been stable for at least 3 months prior to enrollment and their hematologic parameters do not meet the exclusion criteria 1 as outlined below|mycophenolate mofetil[52,73]|||||||||C0209368|68149|68149|mycophenolate mofetil
1	5 Patients on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide are eligible if the dose of the immunosuppressive drug has been stable for at least 3 months prior to enrollment and their hematologic parameters do not meet the exclusion criteria 1 as outlined below|corticosteroid[37,51]||||||||||354|354|corticosteroid
